Tumor angiogenesis: Thrombin and metalloproteinases in focus

Experimental and Molecular Pathology

Volumn 69, Issue 1, 2000, Pages 63-66

  Chiarugi, Vincenzo ^a   Magnelli, Lucia ^a   Dello Sbarba, Persio ^a   Ruggiero, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; METALLOPROTEINASE; THROMBIN;

ARTICLE; BLOOD CLOTTING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOXEMIA; NEOVASCULARIZATION (PATHOLOGY); PROTEIN DEGRADATION;

EID: 0033912870     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2000.2306     Document Type: Article

References (23)

1. Blancher C., Harris A L. The molecular basis of the hypoxia response pathway: Tumor hypoxia as a therapy target. Cancer Metastasis Rev. 17:1998;187-194.
2. Brown J. M., Giaccia A. J. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58:1998;1408-1416.
3. Carmeliet P., Moons L., Dewerchin M., Rosenberg S., Herbert J. M., Lupu F., Collen D. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J. Cell Biol. 140:1998;233-245.
4. Chiarugi V., Magnelli L., Chiarugi A., Gallo O. Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2. J. Cancer Res. Clin. Oncol. 125:1999;525-528.
5. Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor: Vascular endothelial growth factor microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1995;1029-1039.
6. Fibbi G., Caldini R., Chevanne M., Pucci M., Schiavone N., Morbidelli L., Parenti A., Granger H. J., Del Rosso M., Ziche M. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense olygonucleotides against the urokinase receptor. Lab. Invest. 78:1998;1109-1119.
7. Furie B., Furie B. C. Molecular basis of blood coagulation. Hoffman E. J., Benz R. S. Jr., Shattil B., Furie B., Cholmen L., Choen H. J. Hematology: Basic Principles and Practice. 1995;1566-1587 Churchill-Livingstone, New York.
8. Guillemin K., Krasnow M. A. The hypoxic response: Huffing and HIFing. Cell. 89:1977;9-12.
9. Haralabopoulos G. C., Grant D. S., Kleinman H. K., Maragoudakis M. E. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am. J. Physiol. 42:1997;C239-245.
10. Hiraoka N., Allen E., Apel I. J., Gyetko M. R., Weiss S. J. Matrix metalloproteinase regulate neovascularization by acting as pericellular fibrinolysis. Cell. 95:1998;365-377.
11. Korpelainen E. I., Alitalo K. Signalling angiogenesis and lymphangiogenesis. Curr. Opin. Cell. Biol. 10:1998;159-164.
12. Kudelka A. P., Verschraegen C. F., Loyer E. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. N. Engl. J. Med. 338:1998;991-992.
13. Pepper M. S, Montesano R., Mandriota S. J., Orci L., Vassalli J. D. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein. 49:1996;138-162.
14. Sato H., Kinoshita T., Takino T., Nakayama K., Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinase (TIMP)-2. FEBS Lett. 393:1996;101-104.
15. Sato T., Iwai M., Sakai T., Sato H., Seiki M., Mori Y., Ito A. Enhancement of membrane - type 1-matrix metalloproteinase (MT1-MMP) production and of sequential activation of progelatinase-A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Br. J. Cancer. 80:1999;1137-1143.
16. Srinivas V., Zhu X., Salceda S., Nakamura R., Caro J. Hypoxia inducible factor 1alpha (HIF-1alpha) is a non-heme iron protein. Implications for oxygen sensing. J. Biol. Chem. 273:1998;18019-18022.
17. Strongin A. Y., Collier I., Bannikov G., Marmer B. L., Grant G. A., Goldberg G. I. Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270:1995;5331-5338.
18. Tusujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R. M. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716.
19. Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell. 91:1997;439-442.
20. Westermarck J., Kahari V. M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:1999;781-792.
21. Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
22. Zucker S., Conner C., DiMassmo B. J., Ende H., Drews M., Seiki M., Bahou W. F. Thrombin induces the activation of progelatinase-A in vascular endothelial cells: Physiologic regulation of angiogenesis. J. Biol. Chem. 270:1995;23730-23738.
23. Zucker S., Mirza H., Conner C. E., Lorenz A. F., Drews M. H., Bahou W. F., Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase-A activation and cell proliferation. Int. J. Cancer. 75:1988;780-786.